Europäische Union - Deutsch - EMA (European Medicines Agency)

sandoz gmbh - epoetin alfa - anemia; kidney failure, chronic - antianämische präparate - treatment of symptomatic anaemia associated with chronic renal failure (crf) in adult and paediatric patients: , treatment of anaemia associated with chronic renal failure in paediatric and adult patients on haemodialysis and adult patients on peritoneal dialysis;, treatment of severe anaemia of renal origin accompanied by clinical symptoms in adult patients with renal insufficiency not yet undergoing dialysis;, treatment of anaemia and reduction of transfusion requirements in adult patients receiving chemotherapy for solid tumours, malignant lymphoma or multiple myeloma, and at risk of transfusion as assessed by the patient's general status (e. kardiovaskulärer status, vorbestehende anämie bei beginn der chemotherapie).

Schweiz - Deutsch - Swissmedic (Swiss Agency for Therapeutic Products)

sandoz pharmaceuticals ag - epoetinum alfa - injektionslösung in fertigspritzen - epoetinum alfa 1000 u.i., polysorbatum 80, natrii chloridum, natrii dihydrogenophosphas dihydricus, dinatrii phosphas dihydricus, glycinum, aqua ad iniectabile q.s. ad solutionem pro 0.5 ml. - stimulierung der erythropoese - biotechnologika

Schweiz - Deutsch - Swissmedic (Swiss Agency for Therapeutic Products)

sandoz pharmaceuticals ag - epoetinum alfa - injektionslösung in fertigspritzen - epoetinum alfa 2000 u.i., polysorbatum 80, natrii chloridum, natrii dihydrogenophosphas dihydricus, dinatrii phosphas dihydricus, glycinum, aqua ad iniectabile q.s. ad solutionem pro 1 ml. - stimulierung der erythropoese - biotechnologika

Schweiz - Deutsch - Swissmedic (Swiss Agency for Therapeutic Products)

sandoz pharmaceuticals ag - epoetinum alfa - injektionslösung in fertigspritzen - epoetinum alfa 3000 u.i., polysorbatum 80, natrii chloridum, natrii dihydrogenophosphas dihydricus, dinatrii phosphas dihydricus, glycinum, aqua ad iniectabile q.s. ad solutionem pro 0.3 ml. - stimulierung der erythropoese - biotechnologika

Schweiz - Deutsch - Swissmedic (Swiss Agency for Therapeutic Products)

sandoz pharmaceuticals ag - epoetinum alfa - injektionslösung in fertigspritzen - epoetinum alfa 4000 u.i., polysorbatum 80, natrii chloridum, natrii dihydrogenophosphas dihydricus, dinatrii phosphas dihydricus, glycinum, aqua ad iniectabile q.s. ad solutionem pro 0.4 ml. - stimulierung der erythropoese - biotechnologika

Schweiz - Deutsch - Swissmedic (Swiss Agency for Therapeutic Products)

sandoz pharmaceuticals ag - epoetinum alfa - injektionslösung in fertigspritzen - epoetinum alfa 5000 u.i., polysorbatum 80, natrii chloridum, natrii dihydrogenophosphas dihydricus, dinatrii phosphas dihydricus, glycinum, aqua ad iniectabile q.s. ad solutionem pro 0.5 ml. - stimulierung der erythropoese - biotechnologika

Schweiz - Deutsch - Swissmedic (Swiss Agency for Therapeutic Products)

sandoz pharmaceuticals ag - epoetinum alfa - injektionslösung in fertigspritzen - epoetinum alfa 6000 u.i., polysorbatum 80, natrii chloridum, natrii dihydrogenophosphas dihydricus, dinatrii phosphas dihydricus, glycinum, aqua ad iniectabile q.s. ad solutionem pro 0.6 ml. - stimulierung der erythropoese - biotechnologika

Schweiz - Deutsch - Swissmedic (Swiss Agency for Therapeutic Products)

sandoz pharmaceuticals ag - epoetinum alfa - injektionslösung in fertigspritzen - epoetinum alfa 7000 u.i., polysorbatum 80, natrii chloridum, natrii dihydrogenophosphas dihydricus, dinatrii phosphas dihydricus, glycinum, aqua ad iniectabile q.s. ad solutionem pro 0.7 ml. - stimulierung der erythropoese - biotechnologika

Schweiz - Deutsch - Swissmedic (Swiss Agency for Therapeutic Products)

sandoz pharmaceuticals ag - epoetinum alfa - injektionslösung in fertigspritzen - epoetinum alfa 8000 u.i., polysorbatum 80, natrii chloridum, natrii dihydrogenophosphas dihydricus, dinatrii phosphas dihydricus, glycinum, aqua ad iniectabile q.s. ad solutionem pro 0.8 ml. - stimulierung der erythropoese - biotechnologika

Schweiz - Deutsch - Swissmedic (Swiss Agency for Therapeutic Products)

sandoz pharmaceuticals ag - epoetinum alfa - injektionslösung in fertigspritzen - epoetinum alfa 9000 u.i., polysorbatum 80, natrii chloridum, natrii dihydrogenophosphas dihydricus, dinatrii phosphas dihydricus, glycinum, aqua ad iniectabile q.s. ad solutionem pro 0.9 ml. - stimulierung der erythropoese - biotechnologika